Clinical Trial Update: COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV [NA]

View source ↗

Summary

Clinical trial COMPASSION studying SAPIEN interventional heart valve for congenital pulmonary valve issues has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Regurgitation
• Pulmonary Valve Insufficiency

Drugs mentioned

• SAPIEN Interventional Heart Valve

Snippet

Sponsor: Edwards Lifesciences | Conditions: Pulmonary Valve Insufficiency, Pulmonary Regurgitation | NA | Status: COMPLETED | Results posted: 2016-09-01